Real Time Coverage @BIOConvention #BIO2019: Can Genome Editing Fulfill Its Promise and Meet Unmet Medical Needs? Philadelphia PA
October 15, 2019 by sjwilliamspa
Real Time Coverage @BIOConvention #BIO2019: Can Genome Editing Fulfill Its Promise and Meet Unmet Medical Needs? Philadelphia PA
Reporter: Stephen J. Williams, PhD
118A, Level 100
Human gene editing continues to hold a major fascination within a biomedical and biopharmaceutical industries. It’s extraordinary potential is now being realized but important questions as to who will be the beneficiaries of such breakthrough technologies remained to be answered. The session will discuss whether gene editing technologies can alleviate some of the most challenging unmet medical needs. We will discuss how research advances often never reach minority communities and how diverse patient populations will gain access to such breakthrough technologies. It is widely recognize that there are patient voids in the population and we will explore how community health centers might fill this void to ensure that state-of-the-art technologies can reach the forgotten patient groups . We also will touch ethical questions surrounding germline editing and how such research and development could impact the community at large.
Like this:
Like Loading...
Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Conference Coverage with Social Media, CRISPR applied to Human Germ Line, CRISPR/Cas9 & Gene Editing, Disease Biology, Gene Editing Impact on Longevity, Gene Therapy & Gene Editing Development, Genetics & Innovations in Treatment, Genome Biology | Tagged childhood diseases, Congenital disorder, CRISPR, CRISPR –Cas9 system for genetic engineering, CRISPR-based gene editing, CRISPR-Cas9, gene editing, germline editing, germline mutations | Leave a Comment
Leave a Reply